Association of the aromatase gene with Alzheimer's disease in women

Neuroscience Letters

Volumn 468, Issue 3, 2010, Pages 202-206

  Butler, Helen T ^a   Warden, Donald R ^b   Hogervorst, Eva ^c   Ragoussis, Jiannis ^a   Smith, A David ^b   Lehmann, Donald J ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

CYP19A1; Indel; Linkage disequilibrium; Menopause; Microsatellite; Neurosteroid; SNP

Indexed keywords

ANDROGEN; AROMATASE; ESTROGEN;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME LOCALIZATION; FEMALE; GENETIC ASSOCIATION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; MILD COGNITIVE IMPAIRMENT; ONSET AGE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN INTERACTION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AROMATASE; COGNITION DISORDERS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDEL MUTATION; LINKAGE DISEQUILIBRIUM; LONGITUDINAL STUDIES; MALE; MICROSATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS;

EID: 72549092806     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.10.089     Document Type: Article

References (56)

1. Azad N.A., Al Bugami M., and Loy-English I. Gender differences in dementia risk factors. Gend. Med. 4 (2007) 120-129
2. Azcoitia I., Sierra A., Veiga S., and Garcia-Segura L.M. Aromatase expression by reactive astroglia is neuroprotective. Ann. N.Y. Acad. Sci. 1007 (2003) 298-305
3. Baghaei F., Rosmond R., Westberg L., Hellstrand M., Eriksson E., Holm G., and Bjorntorp P. The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women. Obes. Res. 11 (2003) 578-585
4. Behl C., Skutella T., Lezoualc'h F., Post A., Widmann M., Newton C.J., and Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51 (1997) 535-541
5. Bertram L., McQueen M.B., Mullin K., Blacker D., and Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the Alzgene database. Nat. Genet. 39 (2007) 17-23 (Accessed on 17 September 2009)
6. Brann D.W., Dhandapani K., Wakade C., Mahesh V.B., Khan M.M., and Neurotrophic. neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids 72 (2007) 381-405
7. Brinton R.D. Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease. Adv. Drug Deliv. Rev. 60 (2008) 1504-1511
8. Brinton R.D. The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications. Trends Neurosci. 31 (2008) 529-537
9. Callen D.J., Black S.E., Caldwell C.B., and Grady C.L. The influence of sex on limbic volume and perfusion in AD. Neurobiol. Aging 25 (2004) 761-770
10. 12 and serum total homocysteine levels in confirmed Alzheimer's disease. Arch. Neurol. 55 (1998) 1449-1455
11. Combarros O., Cortina-Borja M., Smith A.D., and Lehmann D.J. Epistasis in sporadic Alzheimer's disease. Neurobiol. Aging 30 (2009) 1333-1349
12. Combarros O., Riancho J.A., Infante J., Sañudo C., Llorca J., Zarrabeitia M.T., and Berciano J. Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk. Dement. Geriatr. Cogn. Disord. 20 (2005) 153-157
13. Combarros O., Sánchez-Juan P., Riancho J.A., Mateo I., Rodríguez-Rodríguez E., Infante J., García-Gorostiaga I., Vázquez-Higuera J.L., and Berciano J. Aromatase and interleukin-10 genetic variants interactively modulate Alzheimer's disease risk. J. Neural Trans. 115 (2008) 863-867
14. Combarros O., van Duijn C.M., Hammond N., Belbin O., Arias-Vasquez A., Cortina-Borja M., Lehmann M.G., Aulchenko Y.S., Schuur M., Kolsch H., Heun R., Wilcock G.K., Brown K., Kehoe P.G., Harrison R., Coto E., Alvarez V., Deloukas P., Mateo I., Gwilliam R., Morgan K., Warden D.R., Smith A.D., and Lehmann D.J. Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease. J. Neuroinflamm. 6 (2009) 22
15. Corbo R.M., Gambina G., Ulizzi L., Moretto G., and Scacchi R. Genetic variation of CYP19 (aromatase) gene influences age at onset of Alzheimer's disease in women. Dement. Geriatr. Cogn. Disord. 27 (2009) 513-518
16. Corder E.H., Ghebremedhin E., Taylor M.G., Thal D.R., Ohm T.G., and Braak H. The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex and APOE polymorphism. Ann. N.Y. Acad. Sci. 1019 (2004) 24-28
17. Cortina-Borja M., Smith A.D., Combarros O., and Lehmann D.J. The synergy factor: a statistic to measure interactions in complex diseases. BMC Res. Notes 2 (2009) 105
18. Dimayuga F.O., Reed J.L., Carnero G.A., Wang C., Dimayuga E.R., Dimayuga V.M., Perger A., Wilson M.E., Keller J.N., and Bruce-Keller A.J. Estrogen and brain inflammation: effects on microglial expression of MHC, costimulatory molecules and cytokines. J. Neuroimmunol. 161 (2005) 123-136
19. Dunning A.M., Dowsett M., Healey C.S., Tee L., Luben R.N., Folkerd E., Novik K.L., Kelemen L., Ogata S., Pharoah P.D., Easton D.F., Day N.E., and Ponder B.A. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J. Nation. Cancer Inst. 96 (2004) 936-945
20. Elias M.F., Wolf P.A., D'Agostino R.B., Cobb J., and White L.R. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am. J. Epidemiol. 138 (1993) 353-364
21. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., and van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis; the APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278 (1997) 1349-1356
22. Fratiglioni L., Viitanen M., von Strauss E., Tontodonati V., Herlitz A., and Winblad B. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology 48 (1997) 132-138
23. Fukumoto N., Fujii T., Combarros O., Kamboh M.I., Tsai S.J., Matsushita S., Nacmias B., Comings D.E., Arboleda H., Ingelsson M., Hyman B.T., Akatsu H., Grupe A., Nishimura A.L., Zatz M., Mattila K.M., Rinne J., Goto Y.I., Asada T., Nakamura S., and Kunugi H. Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: New data and meta-analysis. Am. J. Med. Genet. B: Neuropsychiatr. Genet. (2009) [Epub ahead of print]
24. Garcia-Segura L.M., Wozniak A., Azcoitia I., Rodriguez J.R., Hutchison R.E., and Hutchison J.B. Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair. Neuroscience 89 (1999) 567-578
25. Haiman C.A., Hankinson S.E., Spiegelman D., De Vivo I., Colditz G.A., Willett W.C., Speizer F.E., and Hunter D.J. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Int. J. Cancer 87 (2000) 204-210
26. Henderson V.W., Benke K.S., Green R.C., Cupples L.A., and Farrer L.A. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J. Neurol. Neurosurg. Psychiatry 76 (2005) 103-105
27. Hogervorst E., Yaffe K., Richards M., and Huppert F.A. Hormone replacement therapy to maintain cognitive function in women with dementia. Cochrane Database Syst. Rev. (2009) CD003799
28. Hojo Y., Murakami G., Mukai H., Higo S., Hatanaka Y., Ogiue-Ikeda M., Ishii H., Kimoto T., and Kawato S. Estrogen synthesis in the brain-role in synaptic plasticity and memory. Mol. Cell. Endocrinol. 290 (2008) 31-43
29. Huang R., and Poduslo S.E. CYP19 haplotypes increase risk for Alzheimer's disease. J. Med. Genet. 43 (2006) e42
30. Iivonen S., Corder E., Lehtovirta M., Helisalmi S., Mannermaa A., Vepsäläinen S., Hänninen T., Soininen H., and Hiltunen M. Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease. Neurology 62 (2004) 1170-1176
31. Ishunina T.A., Fischer D.F., and Swaab D.F. Estrogen receptor α and its splice variants in the hippocampus in aging and Alzheimer's disease. Neurobiol. Aging 28 (2007) 1670-1681
32. Ishunina T.A., van Beurden D., van der Meulen G., Unmehopa U.A., Hol E.M., Huitinga I., and Swaab D.F. Diminished aromatase immunoreactivity in the hypothalamus but not in the basal forebrain nuclei in Alzheimer's disease. Neurobiol. Aging 26 (2005) 173-194
33. Kivipelto M., Helkala E.L., Laakso M.P., Hänninen T., Hallikainen M., Alhainen K., Iivonen S., Mannermaa A., Tuomilehto J., Nissinen A., and Soininen H. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann. Int. Med. 137 (2002) 149-155
34. Kretz O., Fester L., Wehrenberg U., Zhou L., Brauckmann S., Zhao S., Prange-Kiel J., Naumann T., Jarry H., Frotscher M., and Rune G.M. Hippocampal synapses depend on hippocampal estrogen synthesis. J. Neurosci. 24 (2004) 5913-5921
35. Lehmann D.J., Williams J., McBroom J., and Smith A.D. Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups. Neuroscience 108 (2001) 541-554
36. Letenneur L., Gilleron V., Commenges D., Helmer C., Orgogozo J.M., and Dartigues J.F. Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J. Neurol. Neurosurg. Psychiatry 66 (1999) 177-183
37. Lethaby A., Hogervorst E., Richards M., Yesufu A., and Yaffe K. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst. Rev. (2008) CD003122
38. MacLennan A.H., Henderson V.W., Paine B.J., Mathias J., Ramsay E.N., Ryan P., Stocks N.P., and Taylor A.W. Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. Menopause 13 (2006) 28-36
39. Nilsen J., Irwin R.W., Gallalher T.K., and Brinton R.D. Estradiol in vivo regulation of brain mitochondrial proteome. J. Neurosci. 27 (2007) 14069-14077
40. Paynter R.A., Hankinson S.E., Colditz G.A., Kraft P., Hunter D.J., and De Vivo I. CYP19 (aromatase) haplotypes and endometrial cancer risk. Int. J. Cancer 116 (2005) 267-274
41. Perneczky R., Drzezga A., Diehl-Schmid J., Li Y., and Kurz A. Gender differences in brain reserve: an (18)F-FDG PET study in Alzheimer's disease. J. Neurol. 254 (2007) 1395-1400
42. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., and Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56 (1999) 303-308
43. Pike C.J. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. J. Neurochem. 72 (1999) 1552-1563
44. Ramirez-Lorca R., Grilo A., Martinez-Larrad M.T., Manzano L., Serrano-Hernando F.J., Moron F.J., Perez-Gonzalez V., Gonzalez-Sanchez J.L., Fresneda J., Fernandez-Parrilla R., Moñux G., Molero E., Sanchez E., Martinez-Calatrava M.J., Saban-Ruiz J., Ruiz A., Saez M.E., and Serrano-Rios M. Sex and body mass index specific regulation of blood pressure by CYP19A1 gene variants. Hypertension 50 (2007) 884-890
45. Roselli C.E., Liu M., and Hurn P.D. Brain aromatization: classic roles and new perspectives. Semin. Reprod. Med. 27 (2009) 207-217
46. Sherwin B.B. Estrogen and memory in women: how can we reconcile the findings?. Horm. Behav. 47 (2005) 371-375
47. Shimodaira M., Nakayama T., Sato N., Saito K., Morita A., Sato I., Takahashi T., Soma M., and Izumi Y. Association study of aromatase gene (CYP19A1) in essential hypertension. Int. J. Med. Sci. 5 (2008) 29-35
48. Shumaker S.A., Legault C., Kuller L., Rapp S.R., Thal L., Lane D.S., Fillit H., Stefanick M.L., Hendrix S.L., Lewis C.E., Masaki K., and Coker L.H. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291 (2004) 2947-2958
49. Simpkins J.W., Yang S.H., Sarkar S.N., and Pearce V. Estrogen actions on mitochondria-physiological and pathological implications. Mol. Cell. Endocrinol. 290 (2008) 51-59
50. Stoffel-Wagner B. Neurosteroid biosynthesis in the human brain and its clinical implications. Ann. N.Y. Acad. Sci. 1007 (2003) 64-78
51. Stoffel-Wagner B., Watzka M., Steckelbroeck S., Schwaab R., Schramm J., Bidlingmaier F., and Klingmüller D. Expression of CYP19 (aromatase) mRNA in the human temporal lobe. Biochem. Biophys. Res. Commun. 244 (1998) 768-771
52. Tzourio C., Dufouil C., Ducimetière P., and Alpérovitch A. Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiolology of Vascular Aging, Neurol. 53 (1999) 1948-1952
53. Vegeto E., Belcredito S., Ghisletti S., Meda C., Etteri S., and Maggi A. The endogenous estrogen status regulates microglia reactivity in animal models of neuroinflammation. Endocrinology 147 (2006) 2263-2272
54. Yague J.G., Muñoz A., de Monasterio-Schrader P., Defelipe J., Garcia-Segura L.M., and Azcoitia I. Aromatase expression in the human temporal cortex. Neuroscience 138 (2006) 389-401
55. Zandi P.P., Carlson M.C., Plassman B.L., Welsh-Bohmer K.A., Mayer L.S., Steffens D.C., and Breitner J.C. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288 (2002) 2123-2129
56. Zhang Y., Champagne N., Beitel L.K., Goodyer C.G., Trifiro M., and LeBlanc A. Estrogen and androgen protection of human neurons against intracellular amyloid beta1-42 toxicity through heat shock protein 70. J. Neurosci. 24 (2004) 5315-5321